ID   UTE3
AC   CVCL_VK03
DR   Cosmic; 2640557
DR   Wikidata; Q98134399
RX   PubMed=27894751;
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
RX   PubMed=27894751; DOI=10.1016/j.ygyno.2016.11.023; PMCID=PMC5183545;
RA   Bellone, Stefania
RA   Bignotti, Eliana
RA   Lonardi, Silvia
RA   Ferrari, Francesca
RA   Centritto, Floriana
RA   Masserdotti, Alice
RA   Pettinella, Francesca
RA   Black, Jonathan D.
RA   Menderes, Gulden
RA   Altwerger, Gary
RA   Hui, Pei
RA   Lopez, Salvatore
RA   de Haydu, Christopher
RA   Bonazzoli, Elena
RA   Predolini, Federica
RA   Zammataro, Luca
RA   Cocco, Emiliano
RA   Ferrari, Federico
RA   Ravaggi, Antonella
RA   Romani, Chiara
RA   Facchetti, Fabio
RA   Sartori, Enrico
RA   Odicino, Franco Edoardo
RA   Silasi, Dan-Arin
RA   Litkouhi, Babak
RA   Ratner, Elena
RA   Azodi, Masoud
RA   Schwartz, Peter E.
RA   Santin, Alessandro D.
RT   "Polymerase epsilon (POLE) ultra-mutation in uterine tumors correlates
RT   with T lymphocyte infiltration and increased resistance to
RT   platinum-based chemotherapy in vitro.";
RL   Gynecol. Oncol. 144:146-152(2017).
//